These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 29517548)

  • 1. Impending Atypical Femoral Fracture in a Patient of Breast Cancer With Bone Metastases Receiving Long-term Denosumab.
    Sugihara T; Koizumi M; Hayakawa K; Ito Y; Sata N
    Clin Nucl Med; 2018 May; 43(5):365-366. PubMed ID: 29517548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impending Atypical Femoral Fracture in Patients With Medullary Thyroid Cancer With Skeletal Metastasis Treated With Long-term Bisphosphonate and Denosumab.
    Koizumi M; Gokita T; Toda K
    Clin Nucl Med; 2017 Jun; 42(6):463-464. PubMed ID: 28240655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical femoral fracture associated with bone-modifying agent for bone metastasis of breast cancer: A report of two cases.
    Tateiwa D; Outani H; Iwasa S; Imura Y; Tanaka T; Oshima K; Naka N; Araki N
    J Orthop Surg (Hong Kong); 2017; 25(3):2309499017727916. PubMed ID: 28844196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do femoral fractures in adult patients with osteogenesis imperfecta imitate atypical femoral fractures? A case series.
    Andersen JD; Bünger MH; Rahbek O; Hald JD; Harsløf T; Langdahl BL
    Osteoporos Int; 2019 Feb; 30(2):513-517. PubMed ID: 30448959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atypical femoral fracture after receiving antiresorptive drugs in breast cancer patients with bone metastasis.
    Ota S; Inoue R; Shiozaki T; Yamamoto Y; Hashimoto N; Takeda O; Yoshikawa K; Ito J; Ishibashi Y
    Breast Cancer; 2017 Jul; 24(4):601-607. PubMed ID: 27943163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current Understanding of Epidemiology, Pathophysiology, and Management of Atypical Femur Fractures.
    Starr J; Tay YKD; Shane E
    Curr Osteoporos Rep; 2018 Aug; 16(4):519-529. PubMed ID: 29951870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The incidence of atypical femoral fractures in breast cancer patients with bone metastases who received bisphosphonate treatment.
    Nakata E; Sugihara S; Yamashita N; Osumi S
    J Orthop Sci; 2017 Sep; 22(5):946-950. PubMed ID: 28549530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical femoral fracture in a bisphosphonate-naïve patient on denosumab for osteoporosis.
    Kumar S; Chang R; Reyes M; Diamond T
    Arch Osteoporos; 2022 Oct; 17(1):131. PubMed ID: 36180610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical tibial fracture in breast cancer patient with bone metastasis receiving denosumab therapy: a case report and review of the literature.
    Yanagisawa Y; Suzuki H; Gamada H; Yamazaki M
    J Med Case Rep; 2023 Jun; 17(1):257. PubMed ID: 37340320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous bilateral atypical femoral fracture in a patient receiving denosumab: case report and literature review.
    Selga J; Nuñez JH; Minguell J; Lalanza M; Garrido M
    Osteoporos Int; 2016 Feb; 27(2):827-32. PubMed ID: 26501556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical femoral fracture in patients with bone metastasis receiving denosumab therapy: a retrospective study and systematic review.
    Takahashi M; Ozaki Y; Kizawa R; Masuda J; Sakamaki K; Kinowaki K; Umezu T; Kondoh C; Tanabe Y; Tamura N; Miura Y; Shigekawa T; Kawabata H; Baba N; Iguchi H; Takano T
    BMC Cancer; 2019 Oct; 19(1):980. PubMed ID: 31640606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MANAGEMENT OF ENDOCRINE DISEASE: Atypical femoral fractures: risks and benefits of long-term treatment of osteoporosis with anti-resorptive therapy.
    Adler RA
    Eur J Endocrinol; 2018 Mar; 178(3):R81-R87. PubMed ID: 29339529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical Management of Patients After Atypical Femur Fractures: a Systematic Review and Recommendations From the European Calcified Tissue Society.
    van de Laarschot DM; McKenna MJ; Abrahamsen B; Langdahl B; Cohen-Solal M; Guañabens N; Eastell R; Ralston SH; Zillikens MC
    J Clin Endocrinol Metab; 2020 May; 105(5):1682-99. PubMed ID: 31867670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical femoral fracture in a patient treated with denosumab.
    Khow KS; Yong TY
    J Bone Miner Metab; 2015 May; 33(3):355-8. PubMed ID: 24996528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research.
    Shane E; Burr D; Abrahamsen B; Adler RA; Brown TD; Cheung AM; Cosman F; Curtis JR; Dell R; Dempster DW; Ebeling PR; Einhorn TA; Genant HK; Geusens P; Klaushofer K; Lane JM; McKiernan F; McKinney R; Ng A; Nieves J; O'Keefe R; Papapoulos S; Howe TS; van der Meulen MC; Weinstein RS; Whyte MP
    J Bone Miner Res; 2014 Jan; 29(1):1-23. PubMed ID: 23712442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of bone microarchitecture in postmenopausal women on long-term bisphosphonate therapy with atypical fractures of the femur.
    Zanchetta MB; Diehl M; Buttazzoni M; Galich A; Silveira F; Bogado CE; Zanchetta JR
    J Bone Miner Res; 2014 Apr; 29(4):999-1004. PubMed ID: 24115250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrence of bilateral atypical femoral fractures associated with the sequential use of teriparatide and denosumab: a case report.
    Ramchand SK; Chiang CY; Zebaze RM; Seeman E
    Osteoporos Int; 2016 Feb; 27(2):821-5. PubMed ID: 26458389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predisposing factors associated with atypical femur fracture among postmenopausal Korean women receiving bisphosphonate therapy: 8 years' experience in a single center.
    Koh JH; Myong JP; Yoo J; Lim YW; Lee J; Kwok SK; Park SH; Ju JH
    Osteoporos Int; 2017 Nov; 28(11):3251-3259. PubMed ID: 28748389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New anti-resorptives and antibody mediated anti-resorptive therapy.
    Farrier AJ; Sanchez Franco LC; Shoaib A; Gulati V; Johnson N; Uzoigwe CE; Choudhury MZ
    Bone Joint J; 2016 Feb; 98-B(2):160-5. PubMed ID: 26850419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bisphosphonate-related atypical femoral fracture with bone metastasis of breast cancer: case report and review.
    Hayashi K; Aono M; Shintani K; Kazuki K
    Anticancer Res; 2014 Mar; 34(3):1245-9. PubMed ID: 24596367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.